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Distribution of the major histocompatibility complex antigens
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Distribution of the major histocompatibility complex antigens in human
and rat kidney. We have compared the distribution of the major
histocompatibility complex (MHC) antigens in human and rat kidney
using monospecific antisera to class I and II antigens of the MHC.
FITC/TRITC double immunofluorescence was used to demonstrate
these antigens in frozen sections and the Staphylococcus aureus Cowan
I rosette assay on the cell surface. In both species, the MHC antigens
were prominently present on the passenger leukocytes. Im-
munofluorescence analysis of human kidney demonstrated that the
class I, f32-microglobulin (f32m), and class II antigens were present in
the vascular endothelial cells and class I antigens in the renal tubular
cells. The Staphylococcus assay demonstrated that these antigens were
also exposed on the respective cell surfaces. In clear contrast, in the
rat, class I, the f32m, and class II antigens were absent from the kidney
vascular endothelium of large vessels and intertubular capillaries;
however, large amounts of class II antigens were seen inside the
proximal renal tubular cells. The Staphylococcus assay indicated that
none or very little of these antigens were exposed on the kidney
parenchymal cell surface. These differences may explain why rat renal
transplants are relatively non-immunogenic and easily accepted,
whereas human renal transplant recipients must be immunosuppressed
ad infinitum.
Distribution des antigènes du complexe d'histocompatibilité principal
du rein d'homme et de rat. Nous avons compare Ia distribution des
antigènes du complexe d'histocompatibilité principal (MHC) dans du
rein d'homme et de rat en utilisant des antisérums monospecifiques des
antigénes des classes I et II du MHC. Une double immunofluorescence
FITCITRITC a été utilisée pour démontrer ces antighnes dans des
sections congelées et Ic dosage des rosettes de Staphylocoque doré
Cowan I pour les démontrer a Ia surface cellulaire. Dans les deux
espèces, les antigenes MHC étaient essentiellement presents sur les
leucocytes de passage. L'analyse en immunofluorescence de rein
humain a démontré que les antigènes de classe I, 1 132-microglobuline
(132m) et de classe II étaient presents dans les cellules endothéliales
vasculaires, et ceux de cIasse I dans les cellules tubulaires rénales. Le
dosage Staphylocoque a démontré que ces antigènes étaient également
exposés sur les surfaces cellulaires respectives. Dc facon clairement
opposée, chez le rat, les antigénes de classe I, 1 132m et de classe II
étaient absents de l'endothélium vasculaire renal des gros vaisseaux et
des capillaires intertubulaires; cependant, de grandes quantités
d'antigenes de classe II étaient visibles a l'intérieur des cellules
tubulaires rhnales proximales, L'essai Staphylocoque a indiqué
qu'audun ou trés peu de ces antigènes étaient exposés a Ia surface des
cellules parenchymateuses rénales. Ces differences pourraient
expliquer pourquoi les greffons rénaux de rat sont relativement non
immunogénes Ct facilement tolérés, alors que les receveurs de trans-
plants rénaux humains doivent étre immunodéprimes indéfiniment.
Different types of allografts differ considerably in their ac-
ceptability. For example, kidney allografts across certain his-
tocompatibility barriers in rats [I] and mice [2] may survive
indefinitely, whereas skin allografts are rejected. Liver al-
lografts are usually accepted without immunosuppression in the
pig, but kidney and skin allografts have been rejected [3]. One
striking example of this dichotomy is the behavior of renal
allografts in rat and humans: Rat renal allografts are accepted
nearly invariably after a short period of immunosuppression [41
and/or after elimination of the transplant passenger cells [5]
whereas human renal allograft recipients must be immunosup-
pressed seemingly ad infinitum.
The major histocompatibility complex (MHC) antigens are
the most important immunogens regulating allograft rejection.
Considering the reported differences in the behavior of renal
allografts in rat and humans, we found it interesting to com-
pare—with the same methods—the distribution of the MHC
antigens in these two organs. In addition to evaluating which
anatomical components in rat and human kidney contain MHC
products, we have analyzed which organelles express these
antigens also on the cell surface.
Methods
Biopsy material
Two human kidneys procured, perfused, and stored in
Eurocolins and three biopsy specimens from a macroscopically
normal area from renal cancer specimens provided the human
material. Rat kidneys were procured and perfused with
phosphate-buffered saline (PBS) [6]. Renal tissue samples were
frozen in liquid nitrogen; other pieces were immersed in RPMI-
1640 tissue culture medium (Gibco Pharmaceuticals, Long
Island, New York, USA) containing 5 g bovine serum albumin,
and 1.2 g Hepes per 1 liter of medium for enzymatic disaggrega-
tion and cytological analysis (below).
Fine needle aspiration biopsy specimens of renal transplants
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Fine needle aspiration biopsies (FNAB) were performed on
renal allografts in the context of rejection episodes; part of each
cytological specimen was used for the analysis of MHC antigen
expression as described [7],
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Fig. 1. Binding of staphylococci by human renal endothelial cells (A) and lack of binding to renal tubular cells (B) after treatment with anti-class
II. (xl000)
Chemicals and media
Collagenase, type IV, and DNAse and Hepes buffers were
obtained from Sigma Chemical Co. (St. Louis, Missouri, USA).
Antisera
The monoclonal mouse antibodies against the backbone
molecule of class I (MAS 032), J32-microglobulin (/32m; MAS
018), and class II antigens (MAS 044) of the human HLA
complex and to the backbone of class II antigen of the rat MHC
(MAS 029 and MAS 043) were purchased from Sera-Lab Ltd.,
Crawley Down, Sussex, England. The specificity of these
antibodies has been described [8].
Rabbit antisera to isolated molecules of rat class I antigen and
f32m were received as a gift from Prof. P. Peterson, Uppsala
University, Uppsala, Sweden. The specificity of these antisera
also has been described [9].
AO anti-DA alloantibody was produced by skin grafting and
hyperimmunization with DA lymphocytes and rendered class 11
specific by extensive adsorption over DA erythrocytes.
Rabbit antisera to Factor Vill-related antigen (FVIII R:Ag)
and lysozyme (LZM) were purchased from Behringwerke
(Marburg, Federal Republic of Germany). Rabbit antisera to
vimentin, desmin and keratin have been characterized [10, 11].
Rabbit antisera to brushborder antigen and to Tamm-Horsfall
antigen were gifts from Dr. Aaro Miettinen (Department of
Serology and Bacteriology, University of Helsinki), and have
been characterized earlier [12, 13]. Tetramethyl rhodamine
isothiocynate (TRITC)-conjugated ulex europeus I agglutinin
(TRITC-UEA I) was purchased from Vector Laboratories
(Burlingame, California, USA). Fluorescein isothiocynate
(FITC) coupled goat anti-mouse IgG was purchased from
Cappel Laboratories (Cochranville, Pennsylvania, USA) and
TRITC-coupled swine anti-rabbit IgG from Dakopatts (Copen-
hagen, Denmark).
Frozen section immunofluorescence
The frozen sections were cut, fixed in —20° acetone, exposed
to mouse antibody (1:20), washed and exposed to FITC-
coupled anti-mouse IgG (1:20). For double staining the sections
were subsequently exposed to rabbit anti-vimentin, -keratin, or
-FVIII RA:g or to TRITC-UEA 1(1:20), washed and exposed to
TRITC-coupled swine anti-rabbit IgG (1:20). The specimens
were examined in a microscope (Zeiss Universal, Oberkochen,
Federal Republic of Germany) equipped with an epi-illuminator
IIIRS and filters for FITC and TRITC fluorescence.
Preparation of single cell suspension
After mechanical mincing and incubation (20 minl+37°C) in
collagenase (0.2 mg/mI) and DNAse (0.2 mg/ml) medium, the
dispersed cells were washed twice to remove traces of enzyme.
This treatment does not affect the expression of subclass-
specific surface markers of lymphoid cells, the distribution of
cell surface glycoproteins [14], or the expression of the major
locus MHC antigens on cell (lymphocyte) surface [15].
Staphylococcus rosette assay
A modification of the Staphylococcus aureus Cowan I rosette
assay, based on the analysis of the rosette-forming cells from
May-Grunwald-Giemsa (MGG) stained cytocentrifuged cell
smears, was used [16, 171. This modification makes it possible
to identify morphologically the rosette-forming cell (Fig. 1). We
have previously demonstrated that at a given antiserum con-
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Table 1. Distribution of MHC antigens in frozen section immunofluorescence of human and rat kidney
- -
Kidney component and marker
Glomerulus Tubuli Vascular endothelium
Col-
lecting
ducts
a-keratin
Tissue
macro-
phages
•
a-vimentin
aLZMa
Vascular
endo-
thelium
UEA-I
Epi-
thelium
a-keratin
Mesan-
gium
a-desmin
Distal
Inter-
Proximal a-Tamm- tubular
Horsfall
a-BB GP
Arterial
L M S L
Venous
M S
FVIII R:ag
Humans
MABaclassI'1 +++ — — — — +++ ++ ++ ++ ++ -i-+ ++ +++
MABa82m
MABaclassli
+++
+++
—
—
—
—
— — +++
— —
-I-++
++ ++ +++ + ++ +-i-+ +++ +÷+
—
—
+++
+++
Rat
Raclassl — — — — — — — — — +++
Ra82m
MAB a-Ia
— — — — — — — — — +++
MASO29 + — — +++ — — — — — +++
MASO43 + — — — — — — — +++
Abbreviations: UEA, Ulex europaeus agglutinin; BB, brush border; FVIII R:ag, factor Vill-related antigen; LZM, lysozyme; L, large; M,
medium; S, small; MAB, monoclonal antibody; R, rabbit.
a LZM positive cells were relatively few in number but all of them were obviously MHC expressing.
centration the number of bound staphylococci is directly pro-
portional to the amount of cell-bound antibody [15].
Results
Distribution of the MHC antigens in frozen section
immunofluorescence
The distribution of the MHC antigens in frozen section
immunofluorescence is demonstrated in Table 1 and Figure 2.
In humans certain structures within the glomeruli and the
intertubular parenchyma displayed a strong staining with mono-
clonal antibodies to class I, 2m, and class II antigens of the
human MHC complex. None of the remaining parenchymal
components displayed any reactivity. Double staining with
TRITC-UEA I identified the intra-glomcrular antibody-binding
structures as the glomerular vascular endothelial cells [18, 191,
and double staining with anti-keratin and anti-desmin demon-
strated that the glomerular epithelium or mesangium did not
contain significant amounts of these antigens, Double staining
with TRITC-UEA I and anti-factor VIII R:Ag identified the
intensively stained intertubular structures as intertubular vas-
cular endothelial cells [18, 19]. The vascular endothelium of
larger vessels, including the arterioli and venae, bound these
antibodies somewhat weaker. In addition, the glomerular tufts
and the intertubular spaces contained some solitary cells re-
active with anti-LZM [20]. These cells were also anti-class land
anti-class II positive but could be visualized only with difficulty
because of their overlapping with the vascular endothelium.
These cells probably represent the fixed mononuclear
phagocytes of the renal parenchyma.
In rat no significant binding of rabbit anti-class I and -/32m to
the parenchymal structures (including the vascular endothe-
hum) was observed. Monoclonal antibodies to the class II
antigen did not react with the vascular endothelium of large
vessels or intertubular capillaries; however, the glomerular
endothelial cells were class II positive. Anti-class II bound
strongly to some tubular cells and to solitary cells in the kidney
parenchyma, in particular within the glomerular tufts and
between the tubuli. Double staining with anti-brushborder
antigen demonstrated that the strongly binding tubular compo-
nents were proximal tubular cells [13]. Double-staining with
anti-lysozyme identified some of the positive cells in glomerular
tufts as mononuclear phagocytes [21]; most of the class II
positive glomerular cells, however, were FVIII R:Ag positive
endothelial cells.
Binding of anti-MHC sera on disaggregated kidney
components
Human. In humans (Table 2) the anti-class I antibody bound
to the passenger lymphocytes, monocytes, and macrophages as
well as to the endothelial and (weaker) to kidney tubular cells.
The average binding by the kidney vascular endothelial cells
was 130, 40 and 50% of the mean binding by the (passenger)
lymphocytes in specimens obtained by organ procurement,
surgical biopsy, or by the FNAB, respectively.
The anti-class II antibody bound to the passenger lympho-
cytes, monocytes, and macrophages; the binding of macro-
phages were approximately two times stronger than the mean
binding to lymphocytes. Also, the renal vascular endothelial
cells bound to this antibody; the average binding to endothelial
cells was approximately 60, 40 and 120% of the binding to the
(passenger) lymphocytes in specimens obtained by procure-
ment, surgical biopsy, and FNAB, respectively. No significant
binding of anti-DR antibody to renal tubular cells was observed.
Rat. In rat, rabbit anti-class I, rabbit anti-f32m and AO
anti-DA antisera had a very similar reaction pattern. A positive
reaction was obtained by the passenger lymphocytes,
monocytes, and macrophages (Table 2) and a weak though still
significant reaction by the passenger erythrocytes and granulo-
cytes (not shown). A weak reaction was recorded by the
proximal and distal tubular cells and the endothelial cells; this
reaction was less distinct than, for example, that by the
passenger erythrocytes. The reaction pattern of rabbit anti-
Fig. 2. Double indirect immunofluorescence of
frozen sections of human and rat kidney with
hybridoma antibodies against class II (A, C)
and rabbit anti-F VIII R:Ag (B, D). The bright
peritubular capillary staining of human kidney
with anti-class 11(A) codistributes with FVIII
R:Ag reactivity (B). In rat kidney some
scattered anti-class II reactive cells (C) are seen
in peritubular areas and glomeruli (arrows in
C). In addition some tubules, which were also
reactive in double staining with
anti-brushborder antigen, appeared to express
Ia-like material (double arrow in C). Glomerular
endothelial cells express FVIIIR:Ag in D
partially codistributing with Ia positivity in C.
(Magnifications: A and B, x320; C and D,
x200)
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class II, of the two monoclonal antibodies directed to class II
antigens of the rat MHC, and erythrocyte-adsorbed AD anti-
DA were again concordant. The passenger lymphocytes,
monocytes, and macrophages (Table 2), but not the passenger
erythrocytes and granulocytes (not shown), gave a positive
reaction. No significant reaction was observed with any one of
the renal parenchymal components.
Discussion
The results of this investigation are compatible with several
previous studies and demonstrate significant differences in the
distribution of the major histocompatibility complex antigens
on the different cellular components of human and rat kidney.
As shown earlier by Paul, van Es, and Baldwin [21]; von
Willebrand, Parthenais, and Hayry [15]; Hayry, von Wil-
lebrand, and Andersson [22]; and others [23—25], the class I
MHC antigens in human kidney are distributed over a fairly
wide range and are present, in addition to the passenger cells,
also on the tubular and vascular endothelial cells of the kidney.
The class II antigens are present on most of the endothelial cells
of the vascular tree as their distribution nearly completely
overlaps with UEA I [191. The class II antigens are most
prominent in the glomerular and intertubular capillary endo-
thelium. The Staphylococcus assay demonstrated that they are
-' -
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Table 2. Binding of staphylococci by disaggregated human and rat kidney passenger and parenchymal cells, after treatment with anti-class I
and II antibody
Antiserum
Origin of
tissue
specimen N
Average number of staphylococci per celi (± SD)
Passenger cells
Parenchymal cells
Endothelial
cells
Small
(proximal)
tubular cells
Large
(distal)
tubular cellsLymphocytes Monocytes Macrophages
Humana
MAB a class I Procured (2) 11.2 6,6 15.3 13.1 5.5
(MAS 032) kidney
Surgical
biopsy
FNAB
specimen
(3)
(4)
6.7 0.3
10.1 2.3
4.9 2.0
ND
7.3 2.0
ND
2.5 0.6
5.2 0.5
2.4 0.9
4.4 1.1
—
—
MAB a class II Procured (2) 5.0 10.0 — 2.8 0.6 —
(MAS 044) kidney
Surgical
biopsy
FNAB
(3)
(4)
6.3 0.9
2.5 1.5
6.1 2.9
ND
9.3 1.2
ND
2.5 0.5
3.0 2.5
0.8 0.1
0.9 0.9
—
—
Rata
Raclassl Procured
kidney
(2) 5.9 5.1 4.8 1.8 1.4 0.3
Raf32m Procured
kidney
(2) 5.5 5.2 5.3 1.6 0.9 0.3
R a class II Procured
kidney
(2) 4.2 4.9 4.2 0.8 0.2 0.2
MAB a class II Procured (2) 4.2 4.6 5.4 0.7 0.8 0.0
(MAS 029) kidney
MAB a class II Procured (2) 4.7 4.9 6.4 0.5 0.4 0.1
(MAS 043) kidney
AOaDAI + II" Procured
kidney
(2) 6.5 5.8 6.3 1.1 1.0 1.1
AO a DA jje Procured
kidney
(2) 4.0 4.9 3.7 0.3 0.9 0.2
a The background of control antibody varied between 0.1 and 0.6 staphylococci per cell.
b The — indicates that no or too few cells of this type were present in the specimen for reliable analysis.
The background of corresponding control sera varied, depending on the cell type and the serum, between 0.0 and 1.0 Staphylococci per cell.
d Non-adsorbed.
Adsorbed extensively with DA RBC.
also exposed on the cell surface. This is in striking contrast to
rat kidney, where none of the parenchymal cells carried the
class II antigens on the cell surface. As shown by adsorption
experiments with kidney homogenate [26, 271, the rat kidney
carries substantial amounts of the class II antigen. In contrast to
humans, most of the class II antigen in a rat kidney is localized
intracellularly in the brushborder antigen-expressing proximal
tubular cells [131, as Hart and Fabre [281 suggested. However,
practically none of the antigen is exposed on the cell surface.
An interesting delineation of these findings is made when they
are related to the present knowledge on the immunogenicity of
renal structures in vivo. It is well-known that human renal
allografts are nearly invariably rejected in the absence of
immunosuppression and that the strength of rejection follows
the MHC disparity at least to a certain extent. In attempts to
increase the renal allograft survival by donor pretreatment in
humans, the success has been variable [29, 301. In clear
contrast, the rat kidney parenchymal cells express very little
immunogenic potential [31] and elimination of passenger com-
ponent by treatment of the graft donor with cytotoxic drugs,
nearly invariably results in a distinct prolongation of graft
survival without further immunosuppression [4]. Even a rat
kidney is immunosensitive, however, as shown in the experi-
ments of Lechler and Batchelor [5]: If a recipient rat carrying a
successfully enhanced renal transplant is exposed to the donor
strain dendritic cells, the graft is promptly rejected. Thus,
although (intracellular) class II antigens of the rat kidney are, as
expected [32], non-immunogenic, the vascular endothelial cells
of human kidney, known to be preserved after successful
transplantation [331 seem to provide subsequent stimuli for graft
rejection even after the passenger component has been replaced
by host type [34].
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